Literature DB >> 34138412

Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.

Alejandro F De Nicola1,2, María Meyer3, Laura Garay3,4, Maria Sol Kruse5, Michael Schumacher6, Rachida Guennoun6, Maria Claudia Gonzalez Deniselle3,7.   

Abstract

Progesterone regulates a number of processes in neurons and glial cells not directly involved in reproduction or sex behavior. Several neuroprotective effects are better observed under pathological conditions, as shown in the Wobbler mouse model of amyotrophic laterals sclerosis (ALS). Wobbler mice are characterized by forelimb atrophy due to motoneuron degeneration in the spinal cord, and include microgliosis and astrogliosis. Here we summarized current evidence on progesterone reversal of Wobbler neuropathology. We demonstrated that progesterone decreased motoneuron vacuolization with preservation of mitochondrial respiratory complex I activity, decreased mitochondrial expression and activity of nitric oxide synthase, increased Mn-dependent superoxide dismutase, stimulated brain-derived neurotrophic factor, increased the cholinergic phenotype of motoneurons, and enhanced survival with a concomitant decrease of death-related pathways. Progesterone also showed differential effects on glial cells, including increased oligodendrocyte density and downregulation of astrogliosis and microgliosis. These changes associate with reduced anti-inflammatory markers. The enhanced neurochemical parameters were accompanied by longer survival and increased muscle strength in tests of motor behavior. Because progesterone is locally metabolized to allopregnanolone (ALLO) in nervous tissues, we also studied neuroprotection by this derivative. Treatment of Wobbler mice with ALLO decreased oxidative stress and glial pathology, increased motoneuron viability and clinical outcome in a progesterone-like manner, suggesting that ALLO could mediate some progesterone effects in the spinal cord. In conclusion, the beneficial effects observed in different parameters support the versatile properties of progesterone and ALLO in a mouse model of motoneuron degeneration. The studies foresee future therapeutic opportunities with neuroactive steroids for deadly diseases like ALS.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Allopregnanolone; Amyotrophic lateral sclerosis; Neurodegeneration; Neuroprotection; Progesterone; Wobbler mouse

Mesh:

Substances:

Year:  2021        PMID: 34138412     DOI: 10.1007/s10571-021-01118-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  115 in total

Review 1.  PROGESTATIONAL AGENTS IN CLINICAL OBSTETRICS AND GYNECOLOGY.

Authors:  T E BRAUN
Journal:  Am J Med Sci       Date:  1964-06       Impact factor: 2.378

Review 2.  Gene regulation by steroid hormones.

Authors:  M Beato
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

3.  The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors.

Authors:  D Belelli; M Pistis; J A Peters; J J Lambert
Journal:  Neurochem Int       Date:  1999-05       Impact factor: 3.921

4.  Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model.

Authors:  Roya Aryanpour; Parichehr Pasbakhsh; Kazem Zibara; Zeinab Namjoo; Fatemeh Beigi Boroujeni; Saeed Shahbeigi; Iraj Ragerdi Kashani; Cordian Beyer; Adib Zendehdel
Journal:  Int Immunopharmacol       Date:  2017-08-19       Impact factor: 4.932

Review 5.  Neurosteroids: of the nervous system, by the nervous system, for the nervous system.

Authors:  E E Baulieu
Journal:  Recent Prog Horm Res       Date:  1997

Review 6.  Novel drugs and early polypharmacotherapy in status epilepticus.

Authors:  Marta Amengual-Gual; Iván Sánchez Fernández; Mark S Wainwright
Journal:  Seizure       Date:  2018-08-07       Impact factor: 3.184

Review 7.  Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation.

Authors:  A Bloodsworth; V B O'Donnell; B A Freeman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

8.  Plasminogen activators in the neuromuscular system of the wobbler mutant mouse.

Authors:  B Blondet; G Barlovatz-Meimon; B W Festoff; C Soria; J Soria; F Rieger; D Hantai
Journal:  Brain Res       Date:  1992-05-15       Impact factor: 3.252

9.  GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?

Authors:  S K S Bengtsson; T Bäckström; R Brinton; R W Irwin; M Johansson; J Sjöstedt; M D Wang
Journal:  Neurobiol Stress       Date:  2019-12-20

10.  Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease.

Authors:  Giorgia Boero; Patrizia Porcu; A Leslie Morrow
Journal:  Neurobiol Stress       Date:  2019-11-27
View more
  2 in total

1.  Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.

Authors:  Chiara Tremolanti; Chiara Cavallini; Laurence Meyer; Christian Klein; Eleonora Da Pozzo; Barbara Costa; Lorenzo Germelli; Sabrina Taliani; Christine Patte-Mensah; Ayikoé-Guy Mensah-Nyagan
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.590

2.  Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.

Authors:  Adam C Raikes; Gerson D Hernandez; Dawn C Matthews; Ana S Lukic; Meng Law; Yonggang Shi; Lon S Schneider; Roberta D Brinton
Journal:  Alzheimers Dement (N Y)       Date:  2022-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.